期刊文献+

曲美他嗪对大鼠心肌缺血-再灌注损伤的保护作用 被引量:7

The protective effect of trimetazidine on the myocardial ischemia-reperfusion injury in rats
原文传递
导出
摘要 目的探讨曲美他嗪(TMZ)对缺血-再灌注(I-R)后大鼠心肌细胞凋亡的保护作用。方法 SD大鼠随机分为假手术组(A组)I、-R组(B组)、低浓度TMZ(1 ml/100 g)组(C组)和高浓度TMZ(3 ml/100 g)组(D组),每组6只。制备大鼠心肌I-R模型,采用流式细胞仪(FCM)、原位末端标记(TUNEL)技术、免疫组化检测心肌组织细胞凋亡情况,并观察细胞形态变化。结果 B组细胞凋亡指数、TUNEL阳性细胞数、Bcl-2、Bax较A组增高[(0.2416±0.0263)vs.(0.0469±0.0136),(3.213±0.14)vs.(0.44±0.133),(2.057±0.187)vs.(0.47±0.082),(4.257±0.135)vs.(0.52±0.058)(P<0.05)],而C、D组细胞凋亡指数、TUNEL阳性细胞数、Bax明显下降(P<0.05),D组减低更明显。结论 TMZ可抑制心肌I-R损伤中的细胞凋亡。 Objective To investigate the protective effect of trimethazine(TMZ) on rat myocardial cell apoptosis after ischemia-reperfusion(IR).Methods Twenty-four SD rats were randomly and equally divided into 4 groups of A(sham operated),B(I-R model),C(treated with TMZ 1ml/100g) and D(treated with TMZ 3ml/100g).The myocardial I-R model in rats was established.The myocardial cell apoptosis was respectively detected by flow cytometry(FCM),TUNEL technology and immunohistochemistry,and the changes of cell morphology were observed by microscope.Results The apoptotic index,the positive cell number and the levels of Bcl-2 and Bax were higher in group B than those in group A[(0.2416±0.0263) vs.(0.0469±0.0136),(3.213±0.140) vs.(0.440±0.133),(2.057±0.187) vs.(0.470±0.082),(4.257±0.135) vs.(0.520±0.058)](P0.05),which were much lower in groups of C and D(P0.05).Conclusion TMZ can inhibit cell apoptosis during myocardial I-R,which in turn attenuates I-R injury.
出处 《江苏医药》 CAS CSCD 北大核心 2011年第1期20-22,共3页 Jiangsu Medical Journal
关键词 心肌缺血-再灌注损伤 曲美他嗪 Myocardial ischemia-reperfusion injury Trimetazidine
  • 相关文献

参考文献5

二级参考文献30

共引文献107

同被引文献44

  • 1姜黎,任江华,曹茂银.万爽力对顿抑心肌能量代谢及功能的恢复作用[J].武汉大学学报(医学版),2004,25(4):400-403. 被引量:18
  • 2滕尧文.曲美他嗪治疗不稳定型心绞痛的疗效评价[J].中国心血管病研究,2005,3(3):212-213. 被引量:31
  • 3刘全,程莉,杨洋.冠状动脉内皮细胞在缺血再灌注损伤时的变化和曲美他嗪的保护作用[J].中华老年医学杂志,2006,25(1):71-73. 被引量:16
  • 4中华医学会心血管分会 中华心血管病杂志编辑委员会.慢性收缩性心力衰竭治疗指南.中华心血管病杂志,2007,35(12):1076-1095.
  • 5Maeder MT, Rickli H, Pfisterer ME, et al. Incidence, clinical predic- t0rs,and prognostic impact of worsening renal function in elderly pa- tients with chronic heart failure on intensive medical therapy [ J ]. Am Heart J,2012,163(3) :407-414.
  • 6Lee BS, Choi JY, Kim JY, et al. Simvastatin and losartan differentially and synergistically inhibit atherosclerosis in apolipoproteine ( -/- ) mice [ J ]. Korean Circ J, 2012,42 ( 8 ) : 543 -550.
  • 7Zhang L,Lu Y,Jiang H,et al. Additional use of trimetazidine in pa- tients with chronic heart failure : a meta-analysis [ J ]. J Am Cell Car- diol,2012,59(10) :913-922.
  • 8Lloyd-Jones D, Adams R J, Brown TM, et al. Heart diseae and stroke statistics-2010 update: a report from the American Heart Association[J]. Circulation, 2010, 121(7):e46 - e215.
  • 9Schultz HD, Marcus NJ. Heart failure and carotid body chemoreeeption[J]. Adv Exp Med BioI, 2012, 758(2):387-395.
  • 10Zhang L, Lu Y, Jiang H, et al. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis [J]. J Am Coll Cardiol, 2012, 59(10):913-922.

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部